Cargando…

The Effect of Glycans Steric Potentials on Virus Infectivity- the SARS-Cov-2 Case

Detalles Bibliográficos
Autor principal:	Battaglia, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Biophysical Society 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879824/ http://dx.doi.org/10.1016/j.bpj.2020.11.2070

Ejemplares similares

The Role of Host Cell Glycans on Virus Infectivity: The SARS‐CoV‐2 Case
por: Acosta‐Gutiérrez, Silvia, et al.
Publicado: (2022)

Aglycone sterics-selective enzymatic glycan remodeling
por: Mao, Anwen, et al.
Publicado: (2022)

Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
por: Zhao, Xiaohui, et al.
Publicado: (2021)

Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
por: Allen, Joel D., et al.
Publicado: (2021)

Concerted hinge motions in SARS-CoV-2 spike modulated by glycan-glycan and glycan-lipid interactions
por: Kapoor, Karan, et al.
Publicado: (2022)

Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection
por: Dwivedi, Rohini, et al.
Publicado: (2021)

Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion
por: Dodero-Rojas, Esteban, et al.
Publicado: (2021)

Binding of the SARS-CoV-2 spike protein to glycans
por: Hao, Wei, et al.
Publicado: (2021)

The roles of glycans in the SARS-CoV-2 spike protein
por: Casalino, Lorenzo, et al.
Publicado: (2022)

Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants
por: Lusvarghi, Sabrina, et al.
Publicado: (2023)

Site-specific analysis of the SARS-CoV-2 glycan shield
por: Watanabe, Yasunori, et al.
Publicado: (2020)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2023)

Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
por: Shinnakasu, Ryo, et al.
Publicado: (2021)

Glycan-Based Flow-Through Device for the Detection of SARS-COV-2
por: Baker, Alexander N., et al.
Publicado: (2021)

Site-specific glycan analysis of the SARS-CoV-2 spike
por: Watanabe, Yasunori, et al.
Publicado: (2020)

Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)

The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2022)

Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry
por: Guseman, Alex J., et al.
Publicado: (2022)

Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
por: Breiman, Adrien, et al.
Publicado: (2020)

Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition
por: Allen, Joel D., et al.
Publicado: (2021)

C−X Bond Activation by Palladium: Steric Shielding versus Steric Attraction
por: Hansen, Thomas, et al.
Publicado: (2022)

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)

Targeting spike glycans to inhibit SARS-CoV2 viral entry
por: Guseman, Alex J., et al.
Publicado: (2023)

A glycan gate controls opening of the SARS-CoV-2 spike protein
por: Sztain, Terra, et al.
Publicado: (2021)

Recombinant SARS-CoV-2 S Protein Binds to Glycans of the Lactosamine Family in vitro
por: Ryzhikov, Alexandr B., et al.
Publicado: (2021)

A glycan gate controls opening of the SARS-CoV-2 spike protein
por: Sztain, Terra, et al.
Publicado: (2021)

Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Role for N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity
por: Yang, Qi, et al.
Publicado: (2022)

Characterization and Function of Glycans on the Spike Proteins of SARS-CoV-2 Variants of Concern
por: Zheng, Luping, et al.
Publicado: (2022)

SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged with glycans
por: Huang, Yihan, et al.
Publicado: (2022)

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
por: Murugavelu, Praveenkumar, et al.
Publicado: (2021)

Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein
por: Wang, Yan, et al.
Publicado: (2021)

SEROLOGICAL DIFFERENTIATION OF STERIC ISOMERS
por: Landsteiner, K., et al.
Publicado: (1928)

Contemporaneous SARS-CoV-2-Neutralizing Antibodies Mediated by N-glycan Shields
por: Baghaie, Leili, et al.
Publicado: (2023)

SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung
por: Byrd-Leotis, Lauren, et al.
Publicado: (2021)

Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition
por: Grant, Oliver C., et al.
Publicado: (2020)

Ensemble-based, glycan-dependent epitope analysis of SARS-CoV-2 spike protein
por: Chen, Tianle, et al.
Publicado: (2022)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
por: Nguyen, Kien, et al.
Publicado: (2021)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
por: Nguyen, Kien, et al.
Publicado: (2021)

Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
por: Newby, Maddy L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bl5t396eo8tgkbbdc7i086mg2a